Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Efficacy of esomeprazole for treatment of poorly controlled asthma.

American Lung Association Asthma Clinical Research Centers., Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA.

N Engl J Med. 2009 Apr 9;360(15):1487-99. doi: 10.1056/NEJMoa0806290.

4.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.

Anderson DE, Kew KM, Boyter AC.

Cochrane Database Syst Rev. 2015 Aug 24;(8):CD011397. doi: 10.1002/14651858.CD011397.pub2. Review.

PMID:
26301488
5.

Esomeprazole induced galactorrhea: a novel side effect.

Pipaliya N, Solanke D, Rathi C, Patel R, Ingle M, Sawant P.

Clin J Gastroenterol. 2016 Feb;9(1):13-6. doi: 10.1007/s12328-015-0622-7. Epub 2015 Dec 12. Review.

PMID:
26661629
6.

Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.

Qi Q, Wang R, Liu L, Zhao F, Wang S.

Int J Clin Pharmacol Ther. 2015 Oct;53(10):803-10. doi: 10.5414/CP202396. Review.

PMID:
26329348
7.

The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis.

Chan WW, Chiou E, Obstein KL, Tignor AS, Whitlock TL.

Arch Intern Med. 2011 Apr 11;171(7):620-9. doi: 10.1001/archinternmed.2011.116. Review.

PMID:
21482834
8.

Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.

Kew KM, Dahri K.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011721. doi: 10.1002/14651858.CD011721.pub2. Review.

PMID:
26798035
9.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.

Kew KM, Evans DJ, Allison DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jun 2;(6):CD011438. doi: 10.1002/14651858.CD011438.pub2. Review.

PMID:
26031392
10.

Gastroesophageal reflux disease and asthma.

Parsons JP, Mastronarde JG.

Curr Opin Pulm Med. 2010 Jan;16(1):60-3. doi: 10.1097/MCP.0b013e328332ca2f. Review.

PMID:
19887939
11.

Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.

Teng M, Khoo AL, Zhao YJ, Lin L, Lim BP, Wu TS, Dan YY.

J Clin Pharm Ther. 2015 Aug;40(4):368-75. doi: 10.1111/jcpt.12277. Epub 2015 Apr 20. Review.

PMID:
25893507
12.

The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors.

Boardman HF, Heeley G.

Int J Clin Pharm. 2015 Oct;37(5):709-16. doi: 10.1007/s11096-015-0150-z. Epub 2015 Jun 23. Review.

13.

Reflux in idiopathic pulmonary fibrosis.

Minnis P, Henry K, Keane MP.

QJM. 2016 Jan;109(1):7-10. doi: 10.1093/qjmed/hcv148. Epub 2015 Aug 29. Review. No abstract available.

PMID:
26319930
14.

Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?

Safe M, Chan WH, Leach ST, Sutton L, Lui K, Krishnan U.

World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):531-539. Review.

Supplemental Content

Support Center